We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Radiation Toxicity Studies Should Precede Phase II
FDA: Radiation Toxicity Studies Should Precede Phase II
June 23, 2005
Nonclinical late radiation toxicity studies should be completed and analyzed in animals before drugmakers begin Phase II dose escalation toxicity studies in humans undergoing cancer treatment, the FDA states in a new draft guidance.